SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Biosimilars: Company Strategies to Capture Value from the Biologics Market
3 references·0 citing·13 second hop
Biosimilars: Company Strategies to Capture Value from the Biologics Market (2012)Biosimilars: Company Strategies to Captur…Diagnosing the decline in pharmaceutical R&D efficiency (2012)Diagnosing the decline in pha…The problems with today's pharmaceutical business—an outsider's view (2011)The problems with today's pha…What's fueling the biotech engine? (2007)What's fueling the biotech en…Rise and fall of modern medicine (1999)Can the pharmaceutical industry reduce attrition rates? (2004)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Are Ideas Getting Harder to Find? (2020)Generating Theory by Abduction (2021)Biopharmaceutical benchmarks 2006 (2006)mAbs (2009)What's fueling the biotech engine—2009–2010 (2010)What's fueling the biotech engine—2010 to 2011 (2011)The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance (2017)The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry (2019)Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization (2020)
this work references cited by second hop

References

  • 2012Diagnosing the decline in pharmaceutical R&D efficiency1,978 cited
  • 2007What's fueling the biotech engine?105 cited
  • 2011The problems with today's pharmaceutical business—an outsider's view102 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work